2025
SJR Q3
JCR Q3 · 1,5
57 eşleşen makale
SCIE
Dergi ayrıntısı
Chemical and Pharmaceutical Bulletin
- Yayıncı
- Pharmaceutical Society of Japan
- Ülke
- Japan · Asiatic Region
- Tür
- journal
- ISSN
-
0009236313475223
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,318
- Quartile Q3
- H-Index 109
- Atıf/yayın 1,47
- Doküman (3y) 424
- Atıf (3y) 626
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 1,5
- 5Y JIF 1,6
- JCI 0,3
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Chemistry (miscellaneous) Q3
- Drug Discovery Q3
- Medicine (miscellaneous) Q3
Alanlar
- Chemistry
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS kategorileri
- Chemistry, Medicinal | Chemistry, Multidisciplinary | Pharmacology & Pharmacy
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q3 | 0,318 | 1,5 | 1,6 | 0,3 | Q3 | 109 |
| 2024 | Q3 | Q3 | 0,349 | 1,3 | 1,6 | 0,33 | Q3 | 106 |
| 2023 | Q3 | Q3 | 0,358 | 1,5 | 1,7 | 0,34 | Q3 | 106 |
| 2022 | Q2 | Q3 | 0,433 | 1,7 | 1,8 | 0,36 | Q3 | 106 |
| 2021 | Q2 | Q3 | 0,376 | 1,9 | 1,8 | 0,37 | Q3 | 106 |
| 2020 | Q2 | Q3 | 0,393 | 1,6 | 1,6 | 0,36 | Q3 | 106 |
| 2019 | Q2 | Q3 | 0,365 | 1,4 | 1,4 | 0,4 | Q2 | 106 |
| 2018 | — | Q3 | — | 1,4 | 1,4 | 0,4 | Q2 | — |
| 2017 | Q2 | Q3 | 0,364 | 1,3 | 1,2 | 0,4 | Q2 | 106 |
| 2016 | Q2 | Q3 | 0,397 | 1,1 | 1,3 | — | — | 106 |
| 2015 | Q2 | Q3 | 0,412 | 1,2 | 1,4 | — | — | 106 |
| 2014 | Q2 | Q3 | 0,478 | 1,2 | 1,5 | — | — | 106 |
| 2013 | Q2 | Q3 | 0,567 | 1,4 | 1,6 | — | — | 106 |
| 2012 | Q2 | Q2 | 0,628 | 1,6 | 1,6 | — | — | 106 |
| 2011 | Q2 | Q2 | 0,576 | 1,6 | 1,7 | — | — | 106 |
| 2010 | Q2 | Q2 | 0,604 | 1,5 | 1,6 | — | — | 106 |
| 2009 | — | Q2 | — | 1,7 | 1,7 | — | — | — |
| 2008 | — | Q2 | — | 1,6 | 1,6 | — | — | — |
| 2007 | — | Q2 | — | 1,2 | 1,3 | — | — | — |
| 2006 | — | Q2 | — | 1,3 | — | — | — | — |
| 2005 | — | Q2 | — | 1,2 | — | — | — | — |
| 2004 | — | Q2 | — | 1,2 | — | — | — | — |
| 2003 | — | Q2 | — | 1,1 | — | — | — | — |
| 2002 | — | Q2 | — | 1,1 | — | — | — | — |
| 2001 | — | Q2 | — | 1,1 | — | — | — | — |
| 2000 | — | Q2 | — | 1,2 | — | — | — | — |
| 1999 | — | Q2 | — | 1,2 | — | — | — | — |
| 1998 | — | Q2 | — | 1,1 | — | — | — | — |
| 1997 | — | Q2 | — | 1,2 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | CHEMISTRY, MEDICINAL | SCIE | Q4 | Q4 | 62/72 |
| 2025 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | Q3 | 179/250 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 286/356 |
| 2024 | CHEMISTRY, MEDICINAL | SCIE | Q4 | Q4 | 64/72 |
| 2024 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | Q3 | 170/239 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 285/352 |
| 2023 | CHEMISTRY, MEDICINAL | SCIE | Q4 | Q4 | 57/72 |
| 2023 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | Q3 | 155/231 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q4 | 265/354 |
| 2022 | CHEMISTRY, MEDICINAL | SCIE | Q4 | Q4 | 51/60 |
| 2022 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | Q3 | 129/178 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 237/278 |
| 2021 | CHEMISTRY, MEDICINAL | SCIE | Q4 | Q4 | 54/63 |
| 2021 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | Q3 | 131/179 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 238/279 |
| 2020 | CHEMISTRY, MEDICINAL | SCIE | Q4 | Q4 | 53/62 |
| 2020 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | Q3 | 129/178 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 244/276 |
| 2019 | CHEMISTRY, MEDICINAL | SCIE | Q4 | Q4 | 51/61 |
| 2019 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | Q2 | 124/177 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 233/271 |
| 2018 | CHEMISTRY, MEDICINAL | SCIE | Q4 | Q4 | 49/61 |
| 2018 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | Q2 | 117/172 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 226/267 |
| 2017 | CHEMISTRY, MEDICINAL | SCIE | Q4 | Q4 | 52/59 |
| 2017 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | Q2 | 118/171 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 224/261 |
| 2016 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 50/60 |
| 2016 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 115/166 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 218/257 |
| 2015 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 46/59 |
| 2015 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 102/163 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 210/255 |
| 2014 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 48/59 |
| 2014 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 97/157 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 209/255 |
| 2013 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 44/58 |
| 2013 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 76/148 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 183/256 |
| 2012 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 38/59 |
| 2012 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 67/152 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 175/261 |
| 2011 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 38/59 |
| 2011 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 64/154 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 174/261 |
| 2010 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 32/54 |
| 2010 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 60/147 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 177/252 |
| 2009 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 26/46 |
| 2009 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 52/140 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 156/237 |
| 2008 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 23/41 |
| 2008 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 49/127 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 147/219 |
| 2007 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 26/41 |
| 2007 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 56/128 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 153/205 |
| 2006 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 23/35 |
| 2006 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 50/124 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 141/199 |
| 2005 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 22/34 |
| 2005 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 47/125 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 137/193 |
| 2004 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 23/36 |
| 2004 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 46/125 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 131/187 |
| 2003 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 23/37 |
| 2003 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 45/123 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 131/185 |
| 2002 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 23/35 |
| 2002 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 39/119 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 121/188 |
| 2001 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 21/36 |
| 2001 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 39/118 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 114/186 |
| 2000 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 21/35 |
| 2000 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 35/118 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 100/181 |
| 1999 | CHEMISTRY | SCIE | Q2 | — | 34/121 |
| 1999 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 17/30 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 90/175 |
| 1998 | CHEMISTRY | SCIE | Q2 | — | 35/126 |
| 1998 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 19/30 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 88/178 |
| 1997 | CHEMISTRY | SCIE | Q2 | — | 37/111 |
| 1997 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 18/28 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 84/157 |